National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.
نویسندگان
چکیده
I. OVERVIEW OF ANALYTICAL ISSUES FOR ACUTE CORONARY SYNDROME (ACS) BIOMARKERS ............................................................548 A. Analytical Issues: Background ..........................548 II. ANALYTICAL BIOMARKER ISSUES....................548 A. Cardiac Troponin Specifications .......................548 B. Cardiac Biomarker Turnaround........................549 C. Biomarkers No Longer Recommended for Use in the Context of ACS..............................................549 D. Determining Biomarker Decision Cutoff Characteristics for ACS ...................................................549 E. European Society of Cardiology (ESC)/American College of Cardiology (ACC) Recommendations ........................................................................550 III. REFERENCES .............................................................550 1 Hennepin County Medical Center, Minneapolis, MN. 2 Medical College of Virginia, Richmond, VA. 3 Duke University Medical Center, Durham, NC. 4 University of California at San Francisco, San Francisco, CA. 5 University of Maryland School of Medicine, Baltimore, MD. All relationships with industry for the guidelines committee are reported online at http://www.aacc.org/AACC/members/nacb/LMPG/OnlineGuide/ PublishedGuidelines/ACSHeart/heartpdf.htm . The materials in this publication represent the opinions of the authors and committee members, and do not necessarily represent the official position of the National Academy of Clinical Biochemistry (NACB) or the International Federation of Clinical Chemistry (IFCC). The National Academy of Clinical Biochemistry is the academy of the American Association for Clinical Chemistry. * Address correspondence to this author at: Director, Rapid Response Laboratories, University of Maryland School of Medicine, 22 S. Greene St., Baltimore, MD 21201. Fax 410-328-5880; e-mail [email protected]. This article has been copublished in the April 3, 2007 online issue of Circulation. Previously published online at DOI: 10.1373/clinchem.2006.084715 © 2007 American Association for Clinical Chemistry and the American Heart Association, Inc. Clinical Chemistry 53:4 547–551 (2007) Evidence-Based Laboratory Medicine and Test Utilization
منابع مشابه
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure.
Preamble The National Academy of Clinical Biochemistry’s (NACB) Laboratory Medicine Practice Guidelines (LMPG) for use of cardiac markers in coronary artery diseases were published in July 19991. Since production of this initial document, numerous published studies and presented data have added significantly to the knowledge base for biochemical markers of cardiac injury. This increased knowled...
متن کاملIFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation. International Federation of Clinical Chemistry and Laboratory Medicine.
The field of biochemical markers of cardiac damage is in a dynamic state, with new applications continually appearing and new assays and markers being developed. These significant and sudden advancements in the development of new biochemical assays have led however to several analytical and interpretative problems. In this situation, it is essential that a uniform and rigorous outlook be mainta...
متن کاملNational Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
I. Overview of Analytical Issues for Heart Failure Biomarkers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e95 A. Background. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e95 II. Analytical Biomarker Issues . . . . . . . . . . . . . . . . . . .e96 A. Issues Related to B-Type Natriuretic Peptide (BNP) and N-Terminal proB-Type Natriuretic Peptide (NTproBNP) Measure...
متن کاملNational Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.
The Sixth Conference on the "Standards of Laboratory Practice Series", sponsored by the National Academy of Clinical Biochemistry (NACB), was held on August 4-5, 1998, at the Annual Meeting of the American Association for Clinical Chemistry, in Chicago, IL. An expert committee was assembled to write recommendations on the use of cardiac markers in coronary artery diseases. The NACB Committee pr...
متن کاملNational Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
I. OVERVIEW OF THE ACUTE CORONARY SYNDROME ............................................................e357 A. Definition of Terms............................................e357 B. Pathogenesis and Management of ACS.............e357 II. USE OF BIOCHEMICAL MARKERS IN THE INITIAL EVALUATION OF ACS .........................e358 A. Diagnosis of Myocardial Infarction ...................e358 1. Bioc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation
دوره 115 13 شماره
صفحات -
تاریخ انتشار 2007